1. Trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19;Cao;N Engl J Med.,2020
2. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection;Cheng;Clin Microbiol Rev.,2007
3. From SARS to MERS, thrusting coronaviruses into the spotlight;Song;Viruses.,2019
4. Efficacies of lopinavir/ritonavir and abidol in the treatment of novel coronavirus pneumonia;Jun;Chin J Infect Dis.,2020
5. Results from a single center, open label, randomized, and controlled trial conducted at Shanghai Public Health Clinical Center (SPHCC) of darunavir and cobicistat (DRV/c) in treating laboratory-confirmed 30 COVID-19 patients showed that DRV/c was not effective [consultado 6 Abr 2020]. Disponible en: https://www.jnj.com/lack-of-evidence-to-support-darunavir-based-hiv-treatments-for-coronavirus